Skip to main content
. 2019 Dec 6;35(1):298–305. doi: 10.1080/14756366.2019.1697250

Figure 2.

Figure 2.

The most susceptible NCI cancer cell lines towards the impact of target sulphonamides 5b and 10b according to the GI%.